Did you know?
You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)
Yes, I will post the links for the BD2-selective BET inhibitors and for Framework for Addressing Residual CVD risk to the link library. From what I understand, the BD2-selective compounds described in that paper, including apabetalone, are not selective for the BRD4 protein but also bind to others including BRD2 and BRD3 (possibly others, I don't know). Picaud et al documented this for apabetalone in this PNAS paper.
